# ZC3H18

## Overview
ZC3H18 is a gene that encodes the zinc finger CCCH-type containing 18 protein, which is characterized by its CCCH-type zinc finger motifs involved in RNA binding. This protein plays a significant role in RNA metabolism, particularly in the regulation of RNA production and degradation. It is involved in the decay of nuclear transcripts and the regulation of mRNA levels, influencing both transcription and decay processes. ZC3H18 interacts with various protein complexes, such as the TREX complex and the cap-binding complex (CBC), which are crucial for RNA processing and export. The protein's function is modulated by post-translational modifications, such as phosphorylation, affecting its interaction with histones and its role in RNA metabolism. ZC3H18 is also implicated in the regulation of BRCA1 expression, with significant clinical relevance in cancer, particularly in ovarian and breast cancers, where it influences homologous recombination and sensitivity to DNA-damaging agents (Chi2014A; Kanakkanthara2019ZC3H18; Winczura2018Characterizing).

## Structure
ZC3H18 is a human protein characterized by the presence of CCCH-type zinc finger motifs, which are involved in RNA binding. The primary structure of ZC3H18 includes these zinc finger domains, which are potential RNA-binding domains (Chi2014A). The secondary structure likely involves alpha helices and beta sheets, typical of zinc finger proteins, although specific details are not provided in the context. The tertiary structure is stabilized by zinc ion coordination, which is a common feature of zinc finger proteins. 

ZC3H18 interacts with various protein complexes, such as the TREX complex and the cap-binding complex (CBC), indicating its role in RNA processing and export (Chi2014A; Giacometti2017Mutually). The protein forms distinct complexes with the CBC, competing with PHAX for binding, which suggests a dynamic quaternary structure involving multiple protein interactions (Giacometti2017Mutually). 

Post-translational modifications, such as phosphorylation or ubiquitination, may affect the function and localization of ZC3H18, although specific modifications are not detailed in the context. Splice variant isoforms may exist, potentially altering the protein's structure and function, but these are not explicitly mentioned in the provided sources.

## Function
The ZC3H18 gene encodes a multi-domain protein that plays a crucial role in RNA metabolism, particularly at the interface of RNA production and destruction decisions. It is involved in the decay of nuclear transcripts, such as eRNAs, PROMPTs, and 3' extended small nuclear RNAs, through interactions with the cap-binding complex (CBC) and the nuclear exosome targeting (NEXT) complex (Winczura2018Characterizing). ZC3H18 also participates in the regulation of mRNA levels, influencing both transcription and decay processes. Its interaction with the CBCA complex is essential for its function in mRNA metabolism, affecting the expression of several mRNAs, including BRCA1 and BRCA2 (Winczura2018Characterizing).

ZC3H18 is active in the nucleus, where it is involved in the splicing of cap-proximal pre-mRNA introns and the 3' end processing or decay of various short RNAs. It competes with PHAX for CBCA binding, influencing RNA fate (Winczura2018Characterizing). The protein also plays a role in the nuclear export of intronless mRNAs by interacting with the TREX complex, facilitating the export of specific mRNAs from the nucleus to the cytoplasm (Chi2014A). ZC3H18's function is modulated by post-translational modifications, such as phosphorylation, which affects its interaction with histones and its role in RNA metabolism (Winczura2018Characterizing).

## Clinical Significance
ZC3H18 has been implicated in several diseases due to its role in regulating BRCA1 expression and homologous recombination (HR). In ovarian cancer, particularly high-grade serous ovarian cancer (HGSOC), ZC3H18 is crucial for maintaining BRCA1 expression. Loss of ZC3H18 leads to reduced BRCA1 levels, resulting in HR defects and increased sensitivity to DNA-damaging agents like PARP inhibitors and platinum-based therapies (Kanakkanthara2019ZC3H18). This suggests that ZC3H18 could be a biomarker for identifying patients who might benefit from these treatments (Kanakkanthara2019ZC3H18).

In breast cancer, similar mechanisms are observed, where ZC3H18 depletion disrupts BRCA1 transcription, potentially affecting HR and genomic stability (Kanakkanthara2019ZC3H18). Additionally, ZC3H18 is associated with uveal melanoma, where it acts as a protective factor, negatively correlated with CD47, suggesting a potential role in cancer prognosis (Wan2020Alternative).

Beyond cancer, ZC3H18 is involved in mRNA export processes. Its dysregulation can lead to the accumulation of mRNAs in the nucleus, impacting gene expression and potentially contributing to other diseases (Chi2014A). However, specific clinical implications of ZC3H18 mutations in non-cancerous conditions remain less well-characterized.

## Interactions
ZC3H18 is involved in several interactions with proteins and nucleic acids, playing a crucial role in various cellular processes. It specifically binds to the BRCA1 promoter in ovarian cancer cells, facilitating the recruitment of E2F4 to an adjacent site, which promotes BRCA1 transcription. This interaction prevents E2F1 and DNMT1 from binding, thereby avoiding promoter methylation and repression of BRCA1 expression (Kanakkanthara2019ZC3H18).

ZC3H18 also interacts with the TREX complex, which is essential for the nuclear export of intronless mRNAs. It binds directly to SEP1 RNA, a sub-element of the hepatitis B virus posttranscriptional element (PRE), and interacts with the TREX component Thoc2. This interaction is crucial for recruiting TREX to SEP1-containing mRNAs, facilitating their export from the nucleus (Chi2014A).

In addition to these interactions, ZC3H18 is part of a complex regulatory network involving E2F family members. It modulates the binding of E2F1 and DNMT1 to the BRCA1 promoter, influencing BRCA1 expression and homologous recombination in ovarian cancer cells (Kanakkanthara2019ZC3H18).


## References


[1. (Winczura2018Characterizing) Kinga Winczura, Manfred Schmid, Claudia Iasillo, Kelly R. Molloy, Lea Mørch Harder, Jens S. Andersen, John LaCava, and Torben Heick Jensen. Characterizing zc3h18, a multi-domain protein at the interface of rna production and destruction decisions. Cell Reports, 22(1):44–58, January 2018. URL: http://dx.doi.org/10.1016/j.celrep.2017.12.037, doi:10.1016/j.celrep.2017.12.037. This article has 39 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2017.12.037)

[2. (Giacometti2017Mutually) Simone Giacometti, Nour El Houda Benbahouche, Michal Domanski, Marie-Cécile Robert, Nicola Meola, Michal Lubas, Jakob Bukenborg, Jens S. Andersen, Wiebke M. Schulze, Celine Verheggen, Grzegorz Kudla, Torben Heick Jensen, and Edouard Bertrand. Mutually exclusive cbc-containing complexes contribute to rna fate. Cell Reports, 18(11):2635–2650, March 2017. URL: http://dx.doi.org/10.1016/j.celrep.2017.02.046, doi:10.1016/j.celrep.2017.02.046. This article has 73 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2017.02.046)

[3. (Wan2020Alternative) Qi Wan, Xuan Sang, Lin Jin, and Zhichong Wang. Alternative splicing events as indicators for the prognosis of uveal melanoma. Genes, 11(2):227, February 2020. URL: http://dx.doi.org/10.3390/genes11020227, doi:10.3390/genes11020227. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes11020227)

[4. (Chi2014A) B. Chi, K. Wang, Y. Du, B. Gui, X. Chang, L. Wang, J. Fan, S. Chen, X. Wu, G. Li, and H. Cheng. A sub-element in pre enhances nuclear export of intronless mrnas by recruiting the trex complex via zc3h18. Nucleic Acids Research, 42(11):7305–7318, April 2014. URL: http://dx.doi.org/10.1093/nar/gku350, doi:10.1093/nar/gku350. This article has 46 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gku350)

[5. (Kanakkanthara2019ZC3H18) Arun Kanakkanthara, Catherine J. Huntoon, Xiaonan Hou, Minzhi Zhang, Ethan P. Heinzen, Daniel R. O’Brien, Ann L. Oberg, S. John Weroha, Scott H. Kaufmann, and Larry M. Karnitz. Zc3h18 specifically binds and activates the brca1 promoter to facilitate homologous recombination in ovarian cancer. Nature Communications, October 2019. URL: http://dx.doi.org/10.1038/s41467-019-12610-x, doi:10.1038/s41467-019-12610-x. This article has 15 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-019-12610-x)